Key Financials Snapshot

TTM · Standalone · ₹ in Cr
Market Cap
₹52 Cr.
Stock P/E
15.6
P/B
2.2
Current Price
₹60.2
Book Value
₹ 27.8
Face Value
10
52W High
₹82
52W Low
₹ 41.7
Dividend Yield
—

Amkay Products Overview

Business

Amkay Products Ltd. is an Indian company primarily engaged in the manufacturing, assembly, and trading of a variety of medical devices, disposables, and accessories. Their core business involves producing essential healthcare products used in surgical procedures, patient care, and general medical applications. The company makes money by selling these products to hospitals, clinics, diagnostic centers, healthcare professionals, and distributors, catering to both domestic and potentially international markets.

Revenue Mix

While a detailed breakdown of revenue by specific product segments is not readily available, Amkay Products likely derives revenue from broad categories within the medical supplies sector. These may include:

Surgical Disposables (e.g., masks, gloves, drapes)

Respiratory Care Products (e.g., oxygen masks, nebulizer kits)

Anesthesia Products

Urology and Gastroenterology Products

General Medical Consumables

Due to the nature of their business, the revenue mix would primarily be from the sale of these manufactured and assembled medical accessories.

Industry

The medical equipment and supplies industry in India is characterized by significant growth, driven by expanding healthcare infrastructure, increasing healthcare spending, and a growing population. It is a fragmented industry with both large multinational corporations and numerous domestic players. Amkay Products likely operates in the mid-to-lower end of the value chain, focusing on high-volume, cost-effective disposables and accessories. Its positioning would be as a domestic manufacturer competing on price, quality, and distribution reach, potentially serving a niche or regional market before aspiring for broader penetration. The industry is subject to stringent quality and regulatory standards.

MOAT

For a company in the medical supplies and accessories sector, durable competitive advantages can be challenging to build. Potential advantages for Amkay could include:

Cost Efficiency: Ability to manufacture products at a lower cost than competitors due to efficient operations or local sourcing.

Regulatory Compliance & Certifications: Adherence to national and international quality standards (e.g., ISO, CE Mark) which can act as barriers to entry for new players.

Distribution Network: A well-established distribution network, particularly in specific regions, can provide a logistical advantage.

Product Specialization: Focusing on specific types of medical accessories where it has developed expertise or market acceptance.

However, the sector often faces commoditization, making strong moats difficult to maintain against intense competition.

Growth Drivers

Increasing Healthcare Expenditure: Rising public and private spending on healthcare in India.

Expanding Healthcare Infrastructure: Growth in the number of hospitals, clinics, and diagnostic centers across urban and rural areas.

Medical Tourism: India's growing medical tourism sector increases demand for medical supplies.

Aging Population & Lifestyle Diseases: An increasing elderly population and prevalence of chronic diseases drive demand for ongoing medical care and disposables.

Government Initiatives: Schemes like Ayushman Bharat (PM-JAY) increase access to healthcare, boosting demand for medical consumables.

Focus on Domestic Manufacturing: Government push for "Make in India" can benefit domestic producers.

Risks

Intense Competition: Highly competitive market with established domestic and international players, leading to pricing pressure.

Regulatory Changes: Evolving medical device regulations (e.g., Medical Devices Rules 2017 in India) can increase compliance costs and operational complexities.

Raw Material Price Volatility: Dependence on raw materials (plastics, chemicals, etc.) whose prices can fluctuate.

Product Obsolescence: Rapid technological advancements or changes in medical practices can render existing products obsolete.

Quality Control & Recalls: Any lapse in product quality can lead to recalls, reputational damage, and financial penalties.

Supply Chain Disruptions: Vulnerability to global supply chain issues, especially for imported components.

Economic Slowdown: A downturn in the economy could impact healthcare spending by individuals and institutions.

Management & Ownership

Amkay Products Ltd. is likely a promoter-led company, which is common in India. The promoters would typically hold a significant equity stake, indicating strong alignment between management and shareholder interests. Detailed assessment of management quality, experience, and corporate governance practices would require deeper scrutiny of public filings, annual reports, and independent reviews.

Outlook

Amkay Products operates in a growing and essential sector of the Indian economy. The increasing demand for healthcare services and products, coupled with government support for domestic manufacturing, provides a favorable tailwind for the company. However, the business environment is highly competitive, and the company faces risks from regulatory changes, pricing pressure, and the need for continuous product innovation and quality control. Its ability to scale operations efficiently, manage costs, maintain high-quality standards, and expand its distribution network will be crucial for sustainable growth. The outlook is balanced, presenting both significant opportunities from market expansion and challenges from intense competition and operational complexities inherent in the medical supplies industry.

Amkay Products Share Price

Live · BSE · Inception: 2007
₹ | |
Volume
Price

Key Financials — Profit & Loss

₹ in Cr · Standalone · annual

Amkay Products Quarterly Results

#(Fig in Cr.)
Net Sales
Other Income
Total Income
Total Expenditure
Operating Profit
Interest
Depreciation
Exceptional Income / Expenses
Profit Before Tax
Provision for Tax
Profit After Tax
Adjustments
Profit After Adjustments
Adjusted Earnings Per Share

Amkay Products Profit & Loss

#(Fig in Cr.) Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 41 37 28 31 38
Other Income 0 0 0 1 1
Total Income 41 37 28 32 40
Total Expenditure 36 34 25 28 34
Operating Profit 5 3 4 5 5
Interest 0 0 0 1 0
Depreciation 0 1 1 1 1
Exceptional Income / Expenses 0 0 0 0 0
Profit Before Tax 4 2 2 4 4
Provision for Tax 1 1 1 1 1
Profit After Tax 3 1 2 3 3
Adjustments 0 0 0 0 0
Profit After Adjustments 3 1 2 3 3
Adjusted Earnings Per Share 4.9 2.3 2.4 4.1 3.9

Amkay Products Balance Sheet

#(Fig in Cr.) Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 5 6 8 10 24
Minority's Interest 0 0 0 0 0
Borrowings 1 3 3 1 1
Other Non-Current Liabilities -0 -0 0 -0 -0
Total Current Liabilities 8 6 5 7 5
Total Liabilities 14 16 16 18 30
Fixed Assets 2 4 3 3 4
Other Non-Current Assets 1 2 4 4 8
Total Current Assets 10 10 9 11 17
Total Assets 14 16 16 18 30

Amkay Products Cash Flow

#(Fig in Cr.) Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 0 1 0 0 0
Cash Flow from Operating Activities 3 -0 1 -1 -0
Cash Flow from Investing Activities -2 -3 -1 0 -6
Cash Flow from Financing Activities -1 3 0 0 8
Net Cash Inflow / Outflow 1 -1 -0 0 1
Closing Cash & Cash Equivalent 1 0 0 0 2

Amkay Products Ratios

# Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) 4.91 2.31 2.41 4.13 3.86
CEPS(Rs) 5.36 3.15 3.53 5.01 4.82
DPS(Rs) 0 0 0 0 0
Book NAV/Share(Rs) 7.45 9.75 12.16 15.72 27.8
Core EBITDA Margin(%) 11.28 7.36 11.36 10.72 10.75
EBIT Margin(%) 10.79 6.69 10.2 12.95 12.02
Pre Tax Margin(%) 10.26 5.58 8.41 11.27 11.19
PAT Margin (%) 7.68 4.02 5.51 8.47 8.7
Cash Profit Margin (%) 8.38 5.49 8.05 10.25 10.86
ROA(%) 22.92 10.05 9.84 15.76 14.1
ROE(%) 65.98 26.81 22 29.65 19.6
ROCE(%) 71.91 29.32 24.73 28.84 21.89
Receivable days 36.68 38.62 48.07 45.19 47.54
Inventory Days 2.58 11.36 30.08 48.3 65.31
Payable days 82.74 72.85 71.04 37.58 32.6
PER(x) 0 0 0 0 10.31
Price/Book(x) 0 0 0 0 1.43
Dividend Yield(%) 0 0 0 0 0
EV/Net Sales(x) 0.02 0.12 0.18 0.38 0.93
EV/Core EBITDA(x) 0.15 1.48 1.39 2.56 6.52
Net Sales Growth(%) 0 -10.31 -23.67 11.5 23.56
EBIT Growth(%) 0 -44.4 16.45 41.56 14.69
PAT Growth(%) 0 -53.08 4.57 71.42 26.94
EPS Growth(%) 0 -53.08 4.57 71.44 -6.68
Debt/Equity(x) 0.29 0.7 0.61 0.55 0.11
Current Ratio(x) 1.32 1.57 1.96 1.74 3.66
Quick Ratio(x) 1.28 1.24 1.38 0.89 1.93
Interest Cover(x) 20.54 6.02 5.7 7.7 14.57
Total Debt/Mcap(x) 0 0 0 0 0.08

Growth Rates

Compounded annual
# 1 Year 3 Year 5 Year 10 Year
Sales CAGR +23% +1% — —
Operating Profit CAGR 0% +19% — —
PAT CAGR 0% +44% — —
Share Price CAGR +39% — — —
ROE Average +20% +24% +33% +33%
ROCE Average +22% +25% +35% +35%

Amkay Products Shareholding Pattern

Latest · Sep 2026
100% held
Promoters 73.44 %
FII 0 %
DII (MF + Insurance) 0 %
Public (retail) 26.56 %
# Mar 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
Promoter 73.4473.4473.4473.4473.4473.4473.4473.4473.4473.44
FII 5.250.1600000000
DII 6.28000000000
Public 15.0326.426.5626.5626.5626.5626.5626.5626.5626.56
Others 0000000000
Total 100100100100100100100100100100

Amkay Products Peer Comparison

Medical Equipment/Supplies/Accessories Edit Columns

Amkay Products Quarterly Price

10-year quarterly close · BSE
Show Value Show %

News & Updates

See more…

Amkay Products Pros & Cons

Pros

  • Company has a good return on equity (ROE) track record: 3 Years ROE 24%
  • Debtor days have improved from 37.58 to 32.6days.
  • Company is almost debt free.

Cons

Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

whatsapp